Insider Trading activities of Amicus Therapeutics Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Amicus Therapeutics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Amicus Therapeutics Inc since year 2005. Table 2 shows the detailed insider transactions of Amicus Therapeutics Inc since 2005. The reporting company's ticker symbol is FOLD. The reporting company's CIK number is 1178879.
The total value of stock buying since 2005 is $130,111,734.
The total value of stock sales since 2005 is $215,383,783.
The total value of stock option exercises since 2005 is $12,427,702.


 1   2   3 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Amicus Therapeutics Inc (FOLD).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-06 0 $0 30,000 $300,000 31,629 $314,318
2017-05 0 $0 59,828 $478,624 0 $0
2017-03 0 $0 49,050 $392,400 0 $0
2017-02 0 $0 25,000 $150,000 0 $0
2017-01 0 $0 25,000 $150,000 100,000 $0
2016-12 511,650 $2,428,535 0 $0 0 $0
2016-11 0 $0 33,546 $243,368 2,858 $22,864
2016-10 0 $0 25,000 $181,250 0 $0
2016-09 0 $0 45,500 $339,041 3,500 $28,000
2016-08 0 $0 1,135,458 $7,739,206 0 $0
2016-07 0 $0 20,916 $146,412 0 $0
2016-06 81,300 $592,410 0 $0 0 $0
2016-01 0 $0 0 $0 150,000 $0
2015-12 0 $0 0 $0 25,000 $0
2015-11 10,000 $102,660 0 $0 0 $0
2015-10 800,000 $5,337,750 21,250 $279,117 34,443 $364,211
2015-09 0 $0 55,737 $962,711 28,237 $473,837
2015-07 0 $0 220,524 $3,297,071 226,774 $3,210,384
2015-06 0 $0 224,645 $3,038,793 209,073 $2,818,138
2015-05 0 $0 130,100 $1,410,313 325,000 $0
2015-04 0 $0 46,167 $554,120 46,167 $554,120
2015-03 0 $0 377,696 $4,347,304 374,280 $4,304,056
2015-01 0 $0 4,667 $42,003 4,667 $42,003
2014-12 89,000 $743,951 89,000 $743,951 0 $0
2014-11 2,165,353 $14,172,824 65,353 $522,824 0 $0
2014-10 57,384 $386,733 11,373,209 $60,258,763 0 $0
2014-09 64,257 $391,401 64,257 $391,401 0 $0
2014-08 91,090 $529,756 91,090 $529,756 0 $0
2014-06 4,000,000 $14,000,000 0 $0 16,491 $10,521
2013-11 1,500,000 $3,000,000 0 $0 0 $0
2013-03 25,000 $85,000 0 $0 0 $0
2012-11 1,665 $7,559 0 $0 0 $0
2012-07 2,949,581 $18,582,360 0 $0 0 $0
2012-03 6,410,308 $36,538,754 0 $0 49,931 $31,955
2011-08 10,000 $42,000 0 $0 0 $0
2011-06 20,000 $120,800 0 $0 0 $0
2011-05 0 $0 2,250 $16,875 2,250 $1,435
2010-03 11,898 $43,903 0 $0 0 $0
2009-11 20,000 $82,600 0 $0 0 $0
2009-07 0 $0 50,000 $546,603 0 $0
2009-06 0 $0 9,998 $101,327 0 $0
2009-03 0 $0 2,502 $25,020 1,000 $5,325
2009-02 0 $0 9,408 $92,977 0 $0
2009-01 0 $0 0 $0 4,924 $3,141
2008-12 0 $0 4,573 $38,985 20,098 $12,822
2008-11 0 $0 70,676 $662,758 0 $0
2008-10 0 $0 96,043 $1,083,800 40,000 $119,240
2008-09 0 $0 78,958 $42,540,664 0 $0
2008-08 0 $0 179,212 $2,806,588 1,401 $892
2008-07 0 $0 125,777 $79,015,299 30,000 $19,110
2008-06 0 $0 15,000 $163,741 0 $0
2008-05 0 $0 10,000 $105,229 0 $0
2008-04 0 $0 41,950 $453,327 20,000 $12,740
2008-03 428,376 $13,714,641 10,000 $100,000 0 $0
2008-02 1,292,086 $12,832,012 35,500 $355,702 22,083 $14,088
2008-01 113,700 $1,138,641 10,000 $103,050 20,000 $12,760
2007-12 0 $0 0 $0 15,000 $9,570
2007-08 60,200 $692,220 0 $0 32,366 $20,649
2007-07 119,000 $1,356,351 0 $0 0 $0
2007-06 281,842 $3,188,873 44,894 $673,410 33,736 $21,523

Table 2. Detailed insider stock purchases, sales, and option exercises of Amicus Therapeutics Inc insiders (FOLD)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-06-19 Barth Jay (Chief Medical Officer) Sale 30,000 10.00 300,000
2017-06-19 Barth Jay (Chief Medical Officer) Option Ex 30,000 10.00 300,000
2017-06-15 Barth Jay (Chief Medical Officer) Option Ex 1,629 8.79 14,318
2017-05-19 Do Hung (Chief Science Officer) Sale 29,914 8.00 239,312
2017-05-15 Do Hung (Chief Science Officer) Sale 29,914 8.00 239,312
2017-03-02 Campbell Bradley L (Chief Operating Officer) Sale 49,050 8.00 392,400
2017-02-07 Do Hung (Chief Science Officer) Sale 25,000 6.00 150,000
2017-01-13 Do Hung (Chief Science Officer) Sale 25,000 6.00 150,000
2017-01-03 Campbell Bradley L (Chief Operating Officer) Option Ex 100,000 .00 0
2016-12-30 Perceptive Life Sciences Master Fund Ltd Buy 94,750 4.96 470,054
2016-12-29 Perceptive Life Sciences Master Fund Ltd Buy 94,750 4.85 459,916
2016-12-28 Perceptive Life Sciences Master Fund Ltd Buy 47,375 4.91 232,706
2016-12-23 Perceptive Life Sciences Master Fund Ltd Buy 85,275 4.82 411,025
2016-12-22 Perceptive Life Sciences Master Fund Ltd Buy 189,500 4.51 854,834
2016-11-09 Quimi Daphne (SVP, Finance) Sale 8,546 8.00 68,368
2016-11-09 Quimi Daphne (SVP, Finance) Option Ex 2,858 8.00 22,864
2016-11-01 Do Hung (Chief Science Officer) Sale 25,000 7.00 175,000
2016-10-03 Do Hung (Chief Science Officer) Sale 25,000 7.25 181,250
2016-09-20 Baird William D Iii (Chief Financial Officer) Sale 20,500 8.00 164,041
2016-09-20 Baird William D Iii (Chief Financial Officer) Option Ex 3,500 8.00 28,000
2016-09-06 Do Hung (Chief Science Officer) Sale 25,000 7.00 175,000
2016-08-25 Perceptive Life Sciences Master Fund Ltd Sale 1,100,000 6.81 7,491,000
2016-08-04 Barth Jay (Chief Medical Officer) Sale 10,458 7.00 73,206
2016-08-04 Do Hung (Chief Science Officer) Sale 25,000 7.00 175,000
2016-07-27 Barth Jay (Chief Medical Officer) Sale 20,916 7.00 146,412
2016-06-03 Green Jeremy Buy 66,300 7.20 477,360
2016-06-02 Rosenberg Ellen (General Counsel & Corp. Secy) Buy 15,000 7.67 115,050
2016-01-04 Baird William D Iii (Chief Financial Officer) Option Ex 50,000 .00 0
2016-01-04 Quimi Daphne (Vice President Finance) Option Ex 25,000 .00 0
2016-01-04 Peist Kenneth (VP, Legal & IP) Option Ex 25,000 .00 0
2016-01-04 Campbell Bradley L (Chief Operating Officer) Option Ex 50,000 .00 0
2015-12-03 Barth Jay (Chief Medical Officer) Option Ex 25,000 .00 0
2015-11-10 Mcglynn Margaret G (Director) Buy 10,000 10.27 102,660
2015-10-07 Crowley John F (Chairman & CEO) Option Ex 13,193 6.45 85,094
2015-10-07 Perceptive Life Sciences Master Fund Ltd Buy 50,000 6.27 313,500
2015-10-06 Perceptive Life Sciences Master Fund Ltd Buy 250,000 6.49 1,621,750
2015-10-05 Perceptive Life Sciences Master Fund Ltd Buy 500,000 6.80 3,402,500
2015-10-01 Quimi Daphne (Vice President Finance) Sale 11,250 13.13 147,757
2015-10-01 Quimi Daphne (Vice President Finance) Option Ex 11,250 13.13 147,757
2015-10-01 Peist Kenneth (VP, Legal & IP) Sale 10,000 13.14 131,360
2015-10-01 Peist Kenneth (VP, Legal & IP) Option Ex 10,000 13.14 131,360
2015-09-21 Baird William D Iii (Chief Financial Officer) Sale 15,236 16.78 255,629
2015-09-21 Baird William D Iii (Chief Financial Officer) Option Ex 15,236 16.78 255,629
2015-09-21 Campbell Bradley L (Chief Operating Officer) Sale 13,001 16.78 218,208
2015-09-21 Campbell Bradley L (Chief Operating Officer) Option Ex 13,001 16.78 218,208
2015-09-15 Do Hung (Chief Science Officer) Sale 25,000 17.75 443,675
2015-09-14 Quimi Daphne (Vice President Finance) Sale 2,500 18.08 45,199
2015-07-16 Crowley John F (Chairman & CEO) Sale 16,025 16.00 256,400
2015-07-16 Crowley John F (Chairman & CEO) Option Ex 16,025 16.00 256,400
2015-07-14 Crowley John F (Chairman & CEO) Sale 142,250 15.03 2,137,733
2015-07-14 Crowley John F (Chairman & CEO) Option Ex 142,250 15.03 2,137,733
2015-07-13 Valenzano Ken (SVP, Pharmacology & Biology) Sale 15,000 15.00 225,000
2015-07-13 Valenzano Ken (SVP, Pharmacology & Biology) Option Ex 15,000 15.00 225,000
2015-07-13 Crowley John F (Chairman & CEO) Sale 7,750 15.01 116,312
2015-07-13 Crowley John F (Chairman & CEO) Option Ex 7,750 15.01 116,312
2015-07-13 Sblendorio Glenn (Director) Sale 10,000 15.00 150,000
2015-07-13 Sblendorio Glenn (Director) Option Ex 10,000 15.00 150,000
2015-07-08 Doshi Dipal (SVP Strategy & Bus Dev) Sale 6,250 13.87 86,687
2015-07-07 Doshi Dipal (SVP Strategy & Bus Dev) Option Ex 12,500 .00 0
2015-07-01 Gershkowitz Jayne (SVP, Chief Patient Advocate) Sale 10,649 13.97 148,819
2015-07-01 Gershkowitz Jayne (SVP, Chief Patient Advocate) Option Ex 10,649 13.97 148,819
2015-07-01 Quimi Daphne (Vice President Finance) Sale 2,600 13.98 36,350
2015-07-01 Quimi Daphne (Vice President Finance) Option Ex 2,600 13.98 36,350
2015-07-01 Peist Kenneth (VP, Legal & IP) Sale 10,000 13.98 139,770
2015-07-01 Peist Kenneth (VP, Legal & IP) Option Ex 10,000 13.98 139,770
2015-06-23 Hayden Donald J Jr (Director) Sale 55,000 14.01 770,385
2015-06-23 Hayden Donald J Jr (Director) Option Ex 55,000 14.01 770,385
2015-06-22 Castelli Jeff (SVP, Program Management) Sale 18,981 13.94 264,633
2015-06-22 Castelli Jeff (SVP, Program Management) Option Ex 18,981 13.94 264,633
2015-06-22 Valenzano Ken (SVP, Pharmacology & Biology) Sale 20,500 13.85 284,007
2015-06-22 Valenzano Ken (SVP, Pharmacology & Biology) Option Ex 20,500 13.85 284,007
2015-06-19 Baird William D Iii (Chief Financial Officer) Sale 15,235 13.26 202,061
2015-06-19 Baird William D Iii (Chief Financial Officer) Option Ex 15,235 13.26 202,061
2015-06-19 Dilone Enrique (SVP, Technical Operations) Sale 14,045 13.26 186,278
2015-06-19 Dilone Enrique (SVP, Technical Operations) Option Ex 14,045 13.26 186,278
2015-06-19 Campbell Bradley L (Chief Operating Officer) Sale 13,000 13.26 172,419
2015-06-19 Campbell Bradley L (Chief Operating Officer) Option Ex 13,000 13.26 172,419
2015-06-15 Yu Julie (VP Clinical Ops & Data Mgmt) Sale 8,195 14.17 116,123
2015-06-15 Castelli Jeff (SVP, Program Management) Sale 7,377 14.17 104,532
2015-06-08 Castelli Jeff (SVP, Program Management) Sale 17,312 12.87 222,805
2015-06-08 Castelli Jeff (SVP, Program Management) Option Ex 17,312 12.87 222,805
2015-06-08 Crowley John F (Chairman & CEO) Sale 55,000 13.01 715,550
2015-06-08 Crowley John F (Chairman & CEO) Option Ex 55,000 13.01 715,550
2015-05-11 Yu Julie (VP Clinical Ops & Data Mgmt) Sale 7,500 10.85 81,337
2015-05-11 Castelli Jeff (SVP, Program Management) Sale 10,000 10.84 108,370
2015-05-11 Gershkowitz Jayne (SVP, Chief Patient Advocate) Sale 10,000 10.84 108,390
2015-05-11 Baird William D Iii (Chief Financial Officer) Sale 24,800 10.84 268,807
2015-05-11 Quimi Daphne (VP Finance and Controller) Sale 7,500 10.84 81,307
2015-05-11 Dilone Enrique (SVP, Technical Operations) Sale 10,000 10.85 108,450
2015-05-11 Peist Kenneth (VP, Legal & IP) Sale 12,500 10.84 135,487
2015-05-11 Valenzano Ken (SVP, Pharmacology & Biology) Sale 13,000 10.85 140,998
2015-05-11 Kirk John (VP, Regulatory Affairs) Sale 10,000 10.84 108,360
2015-05-11 Campbell Bradley L (Chief Operating Officer) Sale 24,800 10.84 268,807
2015-05-08 Barth Jay (Chief Medical Officer) Option Ex 25,000 .00 0
2015-05-08 Yu Julie (VP Clinical Ops & Data Mgmt) Option Ex 25,000 .00 0
2015-05-08 Castelli Jeff (SVP, Program Management) Option Ex 25,000 .00 0
2015-05-08 Gershkowitz Jayne (SVP, Chief Patient Advocate) Option Ex 25,000 .00 0
2015-05-08 Baird William D Iii (Chief Financial Officer) Option Ex 50,000 .00 0
2015-05-08 Quimi Daphne (VP Finance and Controller) Option Ex 25,000 .00 0
2015-05-08 Dilone Enrique (SVP, Technical Operations) Option Ex 25,000 .00 0
2015-05-08 Peist Kenneth (VP, Legal & IP) Option Ex 25,000 .00 0
2015-05-08 Valenzano Ken (SVP, Pharmacology & Biology) Option Ex 25,000 .00 0
2015-05-08 Kirk John (VP, Regulatory Affairs) Option Ex 25,000 .00 0
2015-05-08 Campbell Bradley L (Chief Operating Officer) Option Ex 50,000 .00 0
2015-04-15 Valenzano Ken (VP, Pharmacology & Biology) Sale 5,000 12.50 62,500
2015-04-15 Valenzano Ken (VP, Pharmacology & Biology) Option Ex 5,000 12.50 62,500
2015-04-15 Sblendorio Glenn (Director) Sale 20,000 12.50 250,000
2015-04-15 Sblendorio Glenn (Director) Option Ex 20,000 12.50 250,000
2015-04-10 Crowley John F (Chairman & CEO) Sale 11,678 12.00 140,136
2015-04-10 Crowley John F (Chairman & CEO) Option Ex 11,678 12.00 140,136
2015-04-01 Castelli Jeff (VP, Program Management) Sale 9,489 10.70 101,484
2015-04-01 Castelli Jeff (VP, Program Management) Option Ex 9,489 10.70 101,484
2015-03-20 Yu Julie (VP Clinical Ops & Data Mgmt) Sale 7,785 11.51 89,581
2015-03-20 Yu Julie (VP Clinical Ops & Data Mgmt) Option Ex 7,785 11.51 89,581
2015-03-20 Gershkowitz Jayne (VP, Patient Advocacy) Sale 10,648 11.51 122,569
2015-03-20 Gershkowitz Jayne (VP, Patient Advocacy) Option Ex 10,648 11.51 122,569
2015-03-20 Baird William D Iii (Chief Financial Officer) Sale 15,235 11.51 175,293
2015-03-20 Baird William D Iii (Chief Financial Officer) Option Ex 15,235 11.51 175,293
2015-03-20 Dilone Enrique (VP, Technical Operations) Sale 14,045 11.51 161,671
2015-03-20 Dilone Enrique (VP, Technical Operations) Option Ex 14,045 11.51 161,671
2015-03-20 Peist Kenneth (VP, Legal & IP) Sale 10,000 11.52 115,160
2015-03-20 Peist Kenneth (VP, Legal & IP) Option Ex 10,000 11.52 115,160
2015-03-20 Valenzano Ken (VP, Pharmacology & Biology) Sale 20,801 11.71 242,687
2015-03-20 Valenzano Ken (VP, Pharmacology & Biology) Option Ex 19,093 11.60 221,063
2015-03-20 Kirk John (VP, Regulatory Affairs) Sale 10,110 11.51 116,355
2015-03-20 Kirk John (VP, Regulatory Affairs) Option Ex 10,110 11.51 116,355
2015-03-20 Crowley John F (Chairman & CEO) Sale 268,322 11.49 3,082,214
2015-03-20 Crowley John F (Chairman & CEO) Option Ex 268,322 11.49 3,082,214
2015-03-20 Campbell Bradley L (Chief Operating Officer) Sale 12,999 11.51 149,592
2015-03-20 Campbell Bradley L (Chief Operating Officer) Option Ex 12,999 11.51 149,592
2015-01-05 Castelli Jeff (VP, Program Management) Sale 4,667 9.00 42,003
2015-01-05 Castelli Jeff (VP, Program Management) Option Ex 4,667 9.00 42,003
2014-12-04 Crowley John F (Chairman & CEO) Buy 89,000 8.36 743,951
2014-12-04 Crowley John F (Chairman & CEO) Sale 89,000 8.36 743,951
2014-11-25 Castelli Jeff (VP, Program Management) Buy 8,103 8.00 64,824
2014-11-25 Castelli Jeff (VP, Program Management) Sale 8,103 8.00 64,824
2014-11-25 Baird William D Iii (Chief Financial Officer) Buy 10,000 8.00 80,000
2014-11-25 Baird William D Iii (Chief Financial Officer) Sale 10,000 8.00 80,000
2014-11-25 Quimi Daphne (VP Finance and Controller) Buy 3,500 8.00 28,000
2014-11-25 Quimi Daphne (VP Finance and Controller) Sale 3,500 8.00 28,000
2014-11-25 Dilone Enrique (VP, Technical Operations) Buy 7,000 8.00 56,000
2014-11-25 Dilone Enrique (VP, Technical Operations) Sale 7,000 8.00 56,000
2014-11-25 Peist Kenneth (VP, Legal & IP) Buy 4,500 8.00 36,000
2014-11-25 Peist Kenneth (VP, Legal & IP) Sale 4,500 8.00 36,000
2014-11-25 Valenzano Ken (VP, Pharmacology & Biology) Buy 25,000 8.00 200,000
2014-11-25 Valenzano Ken (VP, Pharmacology & Biology) Sale 25,000 8.00 200,000
2014-11-25 Campbell Bradley L (Chief Operating Officer) Buy 7,250 8.00 58,000
2014-11-25 Campbell Bradley L (Chief Operating Officer) Sale 7,250 8.00 58,000
2014-11-19 Perceptive Life Sciences Master Fund Ltd Buy 2,100,000 6.50 13,650,000
2014-10-27 Glaxosmithkline Plc Sale 11,315,825 5.29 59,872,030
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of FOLD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Amicus Therapeutics Inc (symbol FOLD, CIK number 1178879) see the Securities and Exchange Commission (SEC) website.